Malcolm Roy Brandon

Title: Malcolm Roy Brandon: Innovator in Recombinant Polypeptide Production

Introduction

Malcolm Roy Brandon is a notable inventor based in Ivanhoe East, Melbourne, Australia. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant polypeptides. His work has implications for veterinary medicine, providing alternatives to naturally derived hormones.

Latest Patents

Brandon holds a patent for a process for the production of recombinant polypeptides. This innovative process involves culturing unicellular organisms that contain synthetic DNA sequences coding for polypeptides with porcine growth hormone activity. The resulting recombinant polypeptides can be utilized in veterinary compositions as effective substitutes for naturally derived porcine growth hormone. Additionally, the patent describes recombinant DNA processes for preparing the unicellular organisms.

Career Highlights

Throughout his career, Malcolm Roy Brandon has focused on advancing biotechnological methods that enhance animal health. His work has led to the development of effective solutions that benefit the veterinary field. He is associated with Southern Cross Biotech Party, Ltd., where he continues to innovate and contribute to the industry.

Collaborations

Brandon has collaborated with John Spencer Emtage, a fellow innovator in the field. Their partnership has fostered advancements in biotechnology and has led to the successful development of new processes and products.

Conclusion

Malcolm Roy Brandon's contributions to the field of recombinant polypeptide production highlight his role as an influential inventor. His innovative processes not only advance scientific understanding but also provide practical solutions in veterinary medicine.